↓ Skip to main content

A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?

Overview of attention for article published in Translational Neurodegeneration, August 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
6 X users
patent
1 patent

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Published in
Translational Neurodegeneration, August 2021
DOI 10.1186/s40035-021-00250-5
Pubmed ID
Authors

Xiaojiao Xu, Dingding Shen, Yining Gao, Qinming Zhou, You Ni, Huanyu Meng, Hongqin Shi, Weidong Le, Shengdi Chen, Sheng Chen

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 11%
Student > Ph. D. Student 9 8%
Student > Doctoral Student 7 6%
Researcher 6 5%
Student > Master 5 5%
Other 10 9%
Unknown 62 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 17%
Neuroscience 7 6%
Medicine and Dentistry 6 5%
Nursing and Health Professions 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 7 6%
Unknown 67 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2023.
All research outputs
#2,175,165
of 25,411,814 outputs
Outputs from Translational Neurodegeneration
#70
of 385 outputs
Outputs of similar age
#50,681
of 436,898 outputs
Outputs of similar age from Translational Neurodegeneration
#4
of 15 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 385 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.7. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.